116 related articles for article (PubMed ID: 12500856)
1. Thallium-201 imaging in evaluation of Hodgkin's disease.
Dadparvar S; Hussain R; Esteves F; Yu JQ; Grewal RK; Arif S; Cruz R; Barbaria CJ; Woods K; Styler MJ
Cancer J; 2002; 8(6):469-75. PubMed ID: 12500856
[TBL] [Abstract][Full Text] [Related]
2. Comparison of thallium-201 and gallium-67 scintigraphy in the evaluation of non-Hodgkin's lymphoma.
Roach PJ; Cooper RA; Arthur CK; Ravich RB
Aust N Z J Med; 1998 Feb; 28(1):33-8. PubMed ID: 9544384
[TBL] [Abstract][Full Text] [Related]
3. Tl-201 and Ga-67 scintigraphy in non-Hodgkin's lymphoma.
Mansberg R; Wadhwa SS; Mansberg V
Clin Nucl Med; 1999 Apr; 24(4):239-42. PubMed ID: 10466518
[TBL] [Abstract][Full Text] [Related]
4. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
5. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
[TBL] [Abstract][Full Text] [Related]
6. Bone lymphoma. Comparison of Tl-201 and Ga-67 citrate scintigraphy in assessment of treatment response.
Roach PJ; Janicek MJ; Kaplan WD
Clin Nucl Med; 1996 Sep; 21(9):689-94. PubMed ID: 8879868
[TBL] [Abstract][Full Text] [Related]
7. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma.
Waxman AD; Eller D; Ashook G; Ramanna L; Brachman M; Heifetz L; McAndrews P; Bierman H; Taub R; Avedo M; Wall F
J Nucl Med; 1996 Jan; 37(1):46-50. PubMed ID: 8544000
[TBL] [Abstract][Full Text] [Related]
8. Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
Devizzi L; Maffioli L; Bonfante V; Viviani S; Balzarini L; Gasparini M; Valagussa P; Bombardieri E; Santoro A; Bonadonna G
Ann Oncol; 1997; 8 Suppl 1():53-6. PubMed ID: 9187430
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Shen YY; Kao A; Yen RF
Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
[TBL] [Abstract][Full Text] [Related]
10. Gallium-67 scans as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin's disease. A Pediatric Oncology Group study.
Weiner M; Leventhal B; Cantor A; Wimmer R; Berry DL; Cook B; Ducos R
Cancer; 1991 Dec; 68(11):2478-80. PubMed ID: 1933785
[TBL] [Abstract][Full Text] [Related]
11. F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease.
Rini JN; Manalili EY; Hoffman MA; Karayalcin G; Mehrotra B; Tomas MB; Palestro CJ
Clin Nucl Med; 2002 Aug; 27(8):572-7. PubMed ID: 12170002
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin disease: use of Tl-201 to monitor mediastinal involvement after treatment.
Fletcher BD; Xiong X; Kauffman WM; Kaste SC; Hudson MM
Radiology; 1998 Nov; 209(2):471-5. PubMed ID: 9807576
[TBL] [Abstract][Full Text] [Related]
13. Value of low-dose gallium-67 imaging in detection of non-Hodgkin's lymphoma recurrence.
Nakayama M; Sakahara H; Minowa Y; Sasai K; Ishigaki T; Saga T; Nakamoto Y; Yao Z; Hiraoka M; Sakai K; Konishi J
Radiat Med; 1997; 15(2):79-83. PubMed ID: 9192431
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography assessment of splenic size as a predictor of splenic weight and disease involvement in laparotomy staged Hodgkin's disease.
Hancock SL; Scidmore NS; Hopkins KL; Cox RS; Bergin CJ
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):93-9. PubMed ID: 8270463
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy.
Brenot-Rossi I; Bouabdallah R; Di Stefano D; Bardou VJ; Stoppa AM; Camerlo J; Sauvan R; Gastaut JA; Pasquier J
Eur J Nucl Med; 2001 Oct; 28(10):1482-8. PubMed ID: 11685490
[TBL] [Abstract][Full Text] [Related]
16. Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma.
Vose JM; Bierman PJ; Anderson JR; Harrison KA; Dalrymple GV; Byar K; Kessinger A; Armitage JO
J Clin Oncol; 1996 Sep; 14(9):2473-9. PubMed ID: 8823325
[TBL] [Abstract][Full Text] [Related]
17. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Yang CC; Sun SS; Lin CC; Kao CH; Lee CC
Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545
[TBL] [Abstract][Full Text] [Related]
18. Dynamic scintigraphy with thallium-201 chloride (Tl-201) for the diagnosis of tumors of the head and neck.
Sato T; Indo H; Kawabata Y; Iwashita Y; Morita Y; Noikura T; Sugihara K; Mimura T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):228-35. PubMed ID: 11505272
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's disease. Prognostic value of Gallium-67 scintigraphy.
Hervás I; Segura A; López-Tendero P; Bello P; González-Cabezas P; Flores D; Yuste A; Pérez-Velasco R; Girones R; Mateo A
Q J Nucl Med; 2003 Jun; 47(2):101-8. PubMed ID: 12865870
[TBL] [Abstract][Full Text] [Related]
20. High-dose gallium imaging in lymphoma.
Anderson KC; Leonard RC; Canellos GP; Skarin AT; Kaplan WD
Am J Med; 1983 Aug; 75(2):327-31. PubMed ID: 6881185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
